These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 535845)

  • 1. [Therapy of hyperlipoproteinemia. Additive effect of the lipid-lowering agent d-triiodothyronine during dietetic treatment].
    Wilke H; Regler B; Keymling R; Frahm H
    Fortschr Med; 1979 Sep; 97(35):1514-6. PubMed ID: 535845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid-reducing basic diet and serum fatty acid levels].
    Reuter W
    Z Gesamte Inn Med; 1980 Sep; 35(18):701-6. PubMed ID: 7445612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dietetic treatment of hyperlipoproteinemias].
    Louis J; Antoine JM; Pointel JP; Debry G; Drouin P
    Sem Hop; 1983 Sep; 59(32):2273-8. PubMed ID: 6314517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dietary treatment of hyperlipoproteinemia].
    Widhalm K
    Wien Med Wochenschr; 1990 Feb; 140(4):88-93. PubMed ID: 2183475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia.
    Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S; Lucani E
    Clin Ter; 1998; 149(2):115-9. PubMed ID: 9780475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia.
    Phillipson BE; Rothrock DW; Connor WE; Harris WS; Illingworth DR
    N Engl J Med; 1985 May; 312(19):1210-6. PubMed ID: 3990714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diet treatment of hyperliproteinemias].
    Louis J; Antoine JM; Pointel JP; Debry G; Drouin P
    Pathol Biol (Paris); 1983 Apr; 31(4):277-82. PubMed ID: 6346241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in nutrition habits in obesity and hyperlipoproteinemia].
    Heide M
    Z Lymphol; 1985 Dec; 9(2):90-3. PubMed ID: 3004058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.
    Vessby B; Lithell H; Boberg J
    Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].
    Singer P; Hüve J
    Fortschr Med; 1991 Aug; 109(24):476-9. PubMed ID: 1937329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of diabetic dyslipoproteinemia.
    Steinmetz A
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of a basic metabolic diet rich in polyene fatty acids on the pattern of glycerophospholipid fatty acids in patients with hyperlipoproteinemia].
    Reuter W; Heybey U
    Z Gesamte Inn Med; 1984 Mar; 39(6):100-2. PubMed ID: 6730581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
    Kaffarnik H; Schneider J; Schubotz R; Zöfel P; Hausmann L; Goebel KM
    Artery; 1980; 8(6):537-46. PubMed ID: 6114725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diets rich in saturated and polyunsaturated fatty acids: metabolic shifting and cardiac health.
    Diniz YS; Cicogna AC; Padovani CR; Santana LS; Faine LA; Novelli EL
    Nutrition; 2004 Feb; 20(2):230-4. PubMed ID: 14962692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of hyperlipoproteinemia].
    Drexel H; Follath F
    Schweiz Rundsch Med Prax; 1993 Apr; 82(17):506-9. PubMed ID: 8493437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine oil capsule therapy for the treatment of hyperlipidemia.
    Davidson MH; Burns JH; Subbaiah PV; Conn ME; Drennan KB
    Arch Intern Med; 1991 Sep; 151(9):1732-40. PubMed ID: 1888238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.